Corbenic Partners’s Grace Therapeutics, Inc. Common Stock GRCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-3
| Closed | – | – | 198 |
|
|
2017
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 222 |
|
|
2016
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 218 |
|
|
2016
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 225 |
|
|
2016
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 191 |
|
|
2016
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 194 |
|
|
2015
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 204 |
|
|
2015
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 181 |
|
|
2015
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 162 |
|
|
2015
Q1 | $1K | Hold |
3
| – | – | ﹤0.01% | 153 |
|
|
2014
Q4 | $1K | Hold |
3
| – | – | ﹤0.01% | 217 |
|
|
2014
Q3 | $1K | Hold |
3
| – | – | ﹤0.01% | 133 |
|
|
2014
Q2 | $1K | Hold |
3
| – | – | ﹤0.01% | 106 |
|
|
2014
Q1 | $1K | Buy |
+3
| New | +$1K | ﹤0.01% | 106 |
|